Pemetrexed salt and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN Β· China
- Current Assignee / Owner
- CHONGQING PHARMA RES INST
- Publication Date
- 2014-10-15
- Estimated Expiration
- Not applicable Β· inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the fields of synthetic organic chemistry and pharmacy, in particular to a pemetrexed salt, a preparation method thereof, and an application of the pemetrexed salt. Background technique
[0002] Pemetrexed and its salts are disclosed as a variety of folate-dependent enzymes including thymidylate synthase (TS), dihydrofolate reductase (DHFR) and glycinamide ribonucleotide formyltransferase ( GARFT) powerful inhibitors, such as EP334636, EP432677, CN1552713, CN101033227 and other reports, have anticancer activity.
[0003] The disodium salt of pemetrexed, that is, pemetrexed disodium (compound of formula I) has been listed in China, the United States, the European Union and other countries as an anticancer drug. Currently, pemetrexed disodium has been approved for use in the treatment of cancer. Four indications: (1) Combined with cisplatin for the treatment of inoperable malignant pleural mesothelioma, pemetrexed disodium is th...